SEC Info - Third Point LLC, et al. - ‘SC 13D/A’ on 5/22/07 re: PDL Biopharma, Inc.

SEC Info℠

Home

Help

Please Sign In

Third Point LLC, et al. – ‘SC 13D/A’ on 5/22/07 re: PDL Biopharma, Inc.

On: Tuesday, 5/22/07, at 4:30pm ET · Accession #: 899140-7-1037 · File #: 5-43256

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/22/07  Third Point LLC                   SC 13D/A               2:36K  PDL Biopharma, Inc.               Willkie Fa… Gallagher/FA
          Daniel S. Loeb
          Jason Aryeh
          Third Point Offshore Fund, Ltd.

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 4                                       11     42K 
 2: EX-99.1     Letter to Pdli                                         5     22K

Filing Submission 0000899140-07-001037 – SGML Text

Original SGML Text submitted by:	Willkie Farr & Gallagher (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Third Point LLC, et al. – ‘SC 13D/A’ on 5/22/07 re: PDL Biopharma, Inc.

On: Tuesday, 5/22/07, at 4:30pm ET · Accession #: 899140-7-1037 · File #: 5-43256

Previous ‘SC 13D’: ‘SC 13D’ on 5/17/07 · Next: ‘SC 13D/A’ on 5/24/07 · Latest: ‘SC 13D’ on 2/13/24

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

To view the SGML, please refresh this page.

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

To view the SGML, please refresh
this page.